Lomond Therapeutics Holdings, Inc.

CIK 1900520 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Lomond Therapeutics Holdings, Inc..

Recent SEC filings

FiledFormAccession number
Jul 10, 202615-12G0001213900-26-077133
Jul 10, 2026RW0001213900-26-076903
Jul 10, 2026S-8 POS0001213900-26-076906
May 15, 202610-Q0001213900-26-057605
Apr 15, 202610-K0001213900-26-044136
Mar 31, 2026NT 10-K0001213900-26-037599
Jan 13, 20268-K0001213900-26-003905
Jan 13, 20268-K0001213900-26-003908
Nov 14, 202510-Q0001213900-25-110869
Nov 13, 2025SCHEDULE 13G/A0001193805-25-001584
Aug 14, 202510-Q0001213900-25-076735
Aug 1, 2025S-1/A0001213900-25-070684
Jun 20, 20258-K0001213900-25-055832
Jun 20, 20258-K0001213900-25-055832
Jun 18, 2025S-1/A0001213900-25-055292
Jun 18, 2025S-1/A0001213900-25-055292
May 20, 202510-Q0001213900-25-046033
May 15, 2025NT 10-Q0001213900-25-044278
Apr 15, 202510-K0001213900-25-032200
Apr 1, 2025NT 10-K0001213900-25-027157
Mar 28, 20258-K0001013762-25-003645
Mar 26, 2025SCHEDULE 13G0001104659-25-028297
Mar 10, 2025S-1/A0001213900-25-022311
Feb 20, 20258-K0001213900-25-015735
Feb 14, 2025SCHEDULE 13G/A0001213900-25-014240